The advantages of nanomedicines include preferential delivery of the payload directly to tumor tissues. CYT-21625 is the novel, first-in-class gold nanomedicine designed to target tumor vasculature and cancer cells by specifically delivering recombinant human tumor necrosis factor alpha (rhTNF) and a paclitaxel prodrug.

中文翻译：

---

具有转移性甲状腺癌和胰腺神经内分泌肿瘤的小鼠的新型双重作用靶向纳米药物。

纳米药物的优点包括将有效载荷直接直接递送至肿瘤组织。CYT-21625是新颖，一流的金纳米药物，旨在通过特异性递送重组人肿瘤坏死因子α（rhTNF）和紫杉醇前药来靶向肿瘤脉管系统和癌细胞。